BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 26718318)

  • 1. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
    Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
    Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
    Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.
    Prekker ME; Nath DS; Walker AR; Johnson AC; Hertz MI; Herrington CS; Radosevich DM; Dahlberg PS
    J Heart Lung Transplant; 2006 Apr; 25(4):371-8. PubMed ID: 16563963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.
    Hamilton BCS; Dincheva GR; Zhuo H; Golden JA; Brzezinski M; Singer JP; Matthay MA; Kukreja J
    Clin Transplant; 2018 Apr; 32(4):e13210. PubMed ID: 29377268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
    Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Shah P; Arcasoy S; Wilkes DS; Christie JD; Ware LB;
    Am J Transplant; 2014 Feb; 14(2):446-52. PubMed ID: 24400993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of right ventricular function on the development of primary graft dysfunction after lung transplantation.
    Pérez-Terán P; Roca O; Rodríguez-Palomares J; Sacanell J; Leal S; Solé J; Rochera MI; Román A; Ruiz-Rodríguez JC; Gea J; Evangelista A; Masclans JR
    J Heart Lung Transplant; 2015 Nov; 34(11):1423-9. PubMed ID: 26169669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.
    Samano MN; Fernandes LM; Baranauskas JC; Correia AT; Afonso JE; Teixeira RH; Caramori ML; Pêgo-Fernandes PM; Jatene FB
    Transplant Proc; 2012 Oct; 44(8):2462-8. PubMed ID: 23026621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.
    Squiers JJ; Saracino G; Chamogeorgakis T; MacHannaford JC; Rafael AE; Gonzalez-Stawinski GV; Hall SA; DiMaio JM; Lima B
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):263-270. PubMed ID: 28186268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Extravascular Lung Water and Plasma Biomarkers of Acute Lung Injury Precede Oxygenation Impairment in Primary Graft Dysfunction After Lung Transplantation.
    Pottecher J; Roche AC; Dégot T; Helms O; Hentz JG; Schmitt JP; Falcoz PE; Santelmo N; Levy F; Collange O; Uring-Lambert B; Bahram S; Schaeffer M; Meyer N; Geny B; Lassalle P; Diemunsch P; Massard G; Kessler R; Steib A;
    Transplantation; 2017 Jan; 101(1):112-121. PubMed ID: 27495752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation.
    Geube MA; Perez-Protto SE; McGrath TL; Yang D; Sessler DI; Budev MM; Kurz A; McCurry KR; Duncan AE
    Anesth Analg; 2016 Apr; 122(4):1081-8. PubMed ID: 26991618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chest X-ray Sizing for Lung Transplants Reflects Pulmonary Diagnosis and Body Composition and Is Associated With Primary Graft Dysfunction Risk.
    Li D; Weinkauf J; Hirji A; Nagendran J; Kapasi A; Lien D; Halloran K
    Transplantation; 2021 Feb; 105(2):382-389. PubMed ID: 32229774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of preoperative pulmonary artery diastolic pressure on predicting primary graft dysfunction after bilateral lung transplantation for patients with idiopathic pulmonary fibrosis].
    Zhang F; Xu H; Jiang S; Li J; Lu S; Wang D; Zang Z; Pan H; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 May; 29(5):442-447. PubMed ID: 28524034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.
    Diamond JM; Meyer NJ; Feng R; Rushefski M; Lederer DJ; Kawut SM; Lee JC; Cantu E; Shah RJ; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Weill D; Arcasoy S; Shah PD; Belperio JA; Wilkes D; Ware LB; Palmer SM; Christie JD;
    Am J Respir Crit Care Med; 2012 Sep; 186(6):546-52. PubMed ID: 22822025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with early graft dysfunction in cystic fibrosis patients receiving primary bilateral lung transplantation.
    Felten ML; Sinaceur M; Treilhaud M; Roze H; Mornex JF; Pottecher J; Journois D; Fischler M
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):686-90. PubMed ID: 22345188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation.
    Tague LK; Bedair B; Witt C; Byers DE; Vazquez-Guillamet R; Kulkarni H; Alexander-Brett J; Nava R; Puri V; Kreisel D; Trulock EP; Gelman A; Hachem RR
    J Heart Lung Transplant; 2021 Oct; 40(10):1212-1222. PubMed ID: 34353713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative statin use is associated with decreased incidence of primary graft dysfunction after lung transplantation.
    Raphael J; Collins SR; Wang XQ; Scalzo DC; Singla P; Lau CL; Kozower BD; Durieux ME; Blank RS
    J Heart Lung Transplant; 2017 Sep; 36(9):948-956. PubMed ID: 28552627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantation.
    Hoetzenecker K; Schwarz S; Muckenhuber M; Benazzo A; Frommlet F; Schweiger T; Bata O; Jaksch P; Ahmadi N; Muraközy G; Prosch H; Hager H; Roth G; Lang G; Taghavi S; Klepetko W
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2193-2206.e3. PubMed ID: 29653665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis.
    Liu Y; Liu Y; Su L; Jiang SJ
    PLoS One; 2014; 9(3):e92773. PubMed ID: 24658073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.